Please login to the form below

Not currently logged in
Email:
Password:

asset swap

This page shows the latest asset swap news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Under Brandicourt, the French group has already divested its animal health business via a 22.8bn asset-swap deal with Boehringer Ingelheim in 2015 that bolstered Sanofi’s consumer health unit.

Latest news

More from news
Approximately 3 fully matching, plus 46 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    This transaction came as a result of the requirement that Sanofi had to divest certain assets from the Sanofi/ Boehringer Ingelheim asset swap of December 2015, in which Sanofi swapped its

  • The human perspective The human perspective

    Chief among these moves were the German company's exit from the generics business, via a $2.6bn deal with specialty firm Hikma, and its forthcoming asset swap with Sanofi. ... But looking at how a transaction such as the yet-to-be-completed asset swap

  • Deal Watch December 2015 Deal Watch December 2015

    Headline $m. Sanofi / Boehringer Ingelheim. Boehringer Ingelheim / Sanofi. Asset swap. ... 200. Sinclair IS (UK). Alliance. Acquisition - asset. Marketed dermatology range of products (Nov 2015).

  • Pharma deals in June 2015 Pharma deals in June 2015

    Kythera's lead asset is Kybella, previously known as ATX-101, which is an FDA approved, proprietary injectable formulation of a synthetic version of deoxycholic acid for the reduction of submental ... This was the case following the $20bn asset swap deal

  • Allergan and taking a specialised approach Allergan and taking a specialised approach

    But for the likes of GSK, Novartis and Lilly with their asset swap agreement, Forest Laboratories and its acquisition of Actavis, and the various dealings at Merck &Co, BMS, Ranbaxy and

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics